Skip to main content
European Radiology Experimental
Fig. 3 | European Radiology Experimental

Fig. 3

From: Multi-b-value DWI to evaluate the synergistic antiproliferation and anti-heterogeneity effects of bufalin plus sorafenib in an orthotopic HCC model

Fig. 3

Comparisons of diffusion-weighted imaging and histopathological parameters of hepatocellular carcinoma LM3 models among the four groups. The results are expressed as the mean ± standard deviation (*p < 0.05). B Bufalin treatment, BS Bufalin plus sorafenib treatment, C Control, DDC Distributed diffusion coefficient, MD Mean diffusivity, MK Mean kurtosis, MVD Microvessel density, NF Necrotic fraction, S Sorafenib treatment, SD Histopathological standard deviation

Back to article page